I Tepler

1.4k citations

19 papers · 1.1k indexed · h-index 11

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Oncology top 5%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis

Papers in ⓘ

Hematology 8
- Hematopoietic Stem Cell Transplantation 8
Oncology 11
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 4

Co-authors: Rosemary Mazanet (10 shared papers)Gary N. Schwartz (8 shared papers)Lois Ayash (9 shared papers)Catherine Wheeler (4 shared papers)Philip Leder (4 shared papers)C Lynch (3 shared papers)Larry Norton (2 shared papers)Andrew D. Seidman (2 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Blood (2 papers)Stem Cells (1 paper)British Journal of Haematology (1 paper)Transfusion (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

I Tepler

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by I Tepler

Since Specialization

Citations

This map shows the geographic impact of I Tepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Tepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Tepler more than expected).

Fields of papers citing papers by I Tepler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Tepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Tepler. The network helps show where I Tepler may publish in the future.

Co-authors

The 25 scholars most cited alongside I Tepler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I Tepler Line = papers co-authored together I Tepler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. Journal of Clinical Oncology ·Andrew D. Seidman, Clifford A. Hudis, J. Albanell, J Albanel, W P Tong, I Tepler, Violante E. Currie, Mary Ellen Moynahan, Maria Theodoulou, Marc J. Gollub, José Baselga, Larry Norton	1998	318
2	Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer Blood ·AD Elias, Lois Ayash, KC Anderson, M Hunt, Catherine Wheeler, Gary N. Schwartz, I Tepler, Rosemary Mazanet, C Lynch, Stephen Pap	1992	220
3	Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. Journal of Clinical Oncology ·Lois Ayash, Anthony Elias, Catherine Wheeler, E Reich, Gary N. Schwartz, Rosemary Mazanet, I Tepler, D Warren, C Lynch, R Gonin	1994	117
4	Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products. Proceedings of the National Academy of Sciences ·Akira Shimizu, I Tepler, Philip N. Benfey, Elsa H. Berenstein, R P Siraganian, Philip Leder	1988	102
5	Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. PubMed ·P K Pattengale, Timothy A. Stewart, A Leder, Eric Sinn, William J. Muller, I Tepler, Emmett V. Schmidt, Philip Leder	1989	76
6	Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. Journal of Clinical Oncology ·I Tepler, S A Cannistra, Emil Frei, R Gonin, Kenneth C. Anderson, G. D. Demetri, Jonathan M. Niloff, H. M. Goodman, Howard G. Muntz, Michael G. Muto	1993	67
7	Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer JNCI Journal of the National Cancer Institute ·Anthony Elias, Lois Ayash, Emil Frei, Arthur T. Skarin, M Hunt, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, I Tepler, Joseph P. Eder, Mark McCauley, Terence S. Herman, Lowell E. Schnipper, K. H. Antman	1993	44
8	Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. PubMed ·Alby Elias, Lois Ayash, Catherine Wheeler, Gary N. Schwartz, I Tepler, R Gonin, Mary McCauley, Rosemary Mazanet, Lowell E. Schnipper, Emil Frei	1995	32
9	The Gene for the Rat Mast Cell High Affinity IgE Receptor α Chain Journal of Biological Chemistry ·I Tepler, Akira Shimizu, Philip Leder	1989	25
10	Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer. PubMed ·Andrew D. Seidman, C. Hudis, John McCaffrey, Tong Wei, Violante E. Currie, Mary Ellen Moynahan, Maria Theodoulou, I Tepler, Marc J. Gollub, Larry Norton	1997	17
11	Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression British Journal of Haematology ·I Tepler, Anthony Elias, Leslie A. Kalish, Lawrence N. Shulman, Gary M. Strauss, Arthur T. Skarin, Thomas J. Lynch, Daniel Levitt, Debra Resta, G. D. Demetri, Lisa Gaynes, Lowell E. Schnipper	1994	14
12	The gene for the human mast cell high-affinity IgE receptor alpha chain: chromosomal localization to Iq21-q23 and RFLP analysis. PubMed ·I Tepler, Cynthia C. Morton, Akira Shimizu, Randall F. Holcombe, Roger L. Eddy, T.B. Shows, Philip Leder	1989	10
13	Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer Blood ·AD Elias, Lois Ayash, KC Anderson, M Hunt, C Wheeler, Gary N. Schwartz, I Tepler, Rosemary Mazanet, C Lynch, Stephen Pap	1992	9
14	The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy Journal of Hematotherapy ·Anthony Elias, Lois Ayash, I Tepler, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, Lowell E. Schnipper, E Frei, Karen H. Antman	1993	8
15	The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high‐dose chemotherapy support Transfusion ·R.J. Benjamin, L. Linsley, John Axelrod, W. H. Churchill, Colin A. Sieff, Lawrence N. Shulman, AD Elias, Lois Ayash, Marie E. Malachowski, Lynne Uhl, Lisa Gaynes, Mary McCauley, Lynn Thompson, Rosemary Mazanet, Karen Antman, Lionel E. Schnipper, I Tepler, J.H. Antin, Catherine Wheeler	1995	7
16	Low-dose vincristine-associated bilateral vocal cord paralysis. PubMed ·Sarah Ryan, S A DelPrete, P W Weinstein, R B Erichson, Michal Bar, K M Lo, Nir Cohen, I Tepler	1999	7
17	High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age. PubMed ·Karen H. Antman, Lois Ayash, Anthony Elias, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, I Tepler, Schnipper Le, Emil Frei	1994	6
18	GM-CSF mobilized peripheral blood stem cell autografts: The DFCI/BIH experience Stem Cells ·Anthony Elias, Rosemary Mazanet, Kenneth C. Anderson, Lois Ayash, C Wheeler, Gary N. Schwartz, I Tepler, M Hunt, J.D. Critchlow, Lowell E. Schnipper, Emil Frei, Karen H. Antman	1992	5
19	High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions. PubMed ·Anthony Elias, L J Ayash, C Wheeler, G Schwartz, I Tepler, Mark McCauley, Rosemary Mazanet, L Schnipper, E Frei, K H Antman	1994	4

About I Tepler

I Tepler is a scholar working on Hematology, Oncology, Dermatology, Pathology and Forensic Medicine and Cancer Research, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Breast Cancer Treatment Studies (2 papers), Neuroblastoma Research and Treatments (2 papers), Mast cells and histamine (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Hematology (332 citations), Oncology (681 citations), Cancer Research (189 citations), Immunology (136 citations) and Dermatology (56 citations). I Tepler has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Rosemary Mazanet, Gary N. Schwartz, Lois Ayash, Catherine Wheeler, Philip Leder, C Lynch, Larry Norton, Andrew D. Seidman, Mary Ellen Moynahan and Maria Theodoulou. Their work appears in journals such as Journal of Clinical Oncology, Blood, Stem Cells, British Journal of Haematology and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact